Invesco Ltd. Gossamer Bio, Inc. Transaction History

Invesco Ltd.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.96 - $2.92 $31,129 - $94,686	-32,427 Reduced 56.06%	25,420 $32,000
Q4 2022 Feb 13, 2023	SELL	$1.74 - $12.87 $1.6 Million - $11.8 Million	-918,152 Reduced 94.07%	57,847 $125,000
Q3 2022 Nov 14, 2022	BUY	$7.21 - $14.88 $6.61 Million - $13.6 Million	916,979 Added 1553.68%	975,999 $11.7 Million
Q2 2022 Aug 15, 2022	BUY	$5.97 - $9.97 $55,228 - $92,232	9,251 Added 18.59%	59,020 $494,000
Q1 2022 May 16, 2022	BUY	$8.44 - $12.49 $23,058 - $34,122	2,732 Added 5.81%	49,769 $432,000
Q4 2021 Feb 14, 2022	SELL	$10.12 - $14.07 $54,293 - $75,485	-5,365 Reduced 10.24%	47,037 $532,000
Q3 2021 Nov 15, 2021	BUY	$7.25 - $13.23 $24,077 - $43,936	3,321 Added 6.77%	52,402 $659,000
Q2 2021 Aug 17, 2021	BUY	$8.0 - $9.75 $81,160 - $98,913	10,145 Added 26.06%	49,081 $398,000
Q1 2021 May 17, 2021	BUY	$8.63 - $10.94 $235,659 - $298,738	27,307 Added 234.82%	38,936 $360,000
Q4 2020 Feb 16, 2021	BUY	$8.3 - $13.59 $96,520 - $158,038	11,629 New	11,629 $112,000

108

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $93M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.